Screening breast cancer patients for Norwegian ATM mutations

被引:9
|
作者
Laake, K
Vu, P
Andersen, TI
Erikstein, B
Kåresen, R
Lonning, PE
Skovlund, E
Borresen-Dale, AL [1 ]
机构
[1] Norwegian Radium Hosp, Dept Genet, N-0310 Oslo, Norway
[2] Univ Oslo, Ulleval Hosp, Dept Oncol, N-0407 Oslo, Norway
[3] Univ Oslo, Ulleval Hosp, Dept Surg, N-0407 Oslo, Norway
[4] Norwegian Radium Hosp, Dept Oncol, N-0310 Oslo, Norway
[5] Norwegian Radium Hosp, Clin Res Off, N-0310 Oslo, Norway
[6] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway
关键词
ataxia telangiectasia; breast neoplasms; heterozygote detection; polymerase chain reaction; breast cancer risk; Norwegian founder mutation;
D O I
10.1054/bjoc.2000.1519
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
483 Norwegian breast cancer patients were screened for six different ataxia telangiectasia mutated (ATM) mutations previously found to account for 83% of the disease alleles in Norwegian ataxia telangiectasia (AT) patients. Only one carrier was found. These results provide no evidence in favour of an excess risk of breast cancer associated with heterozygosity for classical AT mutations, but remain consistent with a maximum 2.4-fold increased risk. (C) 2000 Cancer Research Campaign.
引用
收藏
页码:1650 / 1653
页数:4
相关论文
共 50 条
  • [1] Screening breast cancer patients for Norwegian ATM mutations
    K Laake
    P Vu
    TI Andersen
    B Erikstein
    R Kåresen
    PE Lønning
    E Skovlund
    A-L Børresen-Dale
    Breast Cancer Research, 2 (Suppl 1)
  • [2] Screening breast cancer patients for Norwegian ATM mutations
    K Laake
    P Vu
    T I Andersen
    B Erikstein
    R Kåresen
    P E Lønning
    E Skovlund
    A L Børresen-Dale
    British Journal of Cancer, 2000, 83 : 1650 - 1653
  • [3] ATM mutations in Finnish breast cancer patients
    Allinen, M
    Launonen, V
    Laake, K
    Jansen, L
    Huusko, P
    Kääriäinen, H
    Borresen-Dale, AL
    Winqvist, R
    JOURNAL OF MEDICAL GENETICS, 2002, 39 (03) : 192 - 196
  • [4] ATM missense mutations are frequent in patients with breast cancer
    Sommer, SS
    Jiang, ZF
    Feng, JM
    Buzin, CH
    Zheng, J
    Longmate, J
    Jung, M
    Moulds, J
    Dritschilo, A
    CANCER GENETICS AND CYTOGENETICS, 2003, 145 (02) : 115 - 120
  • [5] Clinical characteristics of breast cancer patients with ATM mutations
    Militello, Loredana
    Barrera, Angelica M. Gutierrez
    Albarracin, Constance
    Bedrosian, Isabelle
    Arun, Banu K.
    CANCER RESEARCH, 2020, 80 (04)
  • [6] ATM heterozygosity and breast cancer:: screening of 37 breast cancer patients for ATM mutations using a non-isotopic RNase cleavage-based
    Drumea, KC
    Levine, E
    Bernstein, J
    Shank, B
    Green, S
    Kaplan, E
    Mandell, L
    Cropley, J
    Obropta, J
    Braccia, I
    Krupnik, A
    Rosenstein, BS
    BREAST CANCER RESEARCH AND TREATMENT, 2000, 61 (01) : 79 - 85
  • [7] ATM heterozygosity and breast cancer: screening of 37 breast cancer patients for ATM mutations using a non-isotopic RNase cleavage-based assay
    Karen C. Drumea
    Eva Levine
    Jonine Bernstein
    Brenda Shank
    Sheryl Green
    Edward Kaplan
    Lynda Mandell
    Joan Cropley
    Juliette Obropta
    Irene Braccia
    Amy Krupnik
    Barry S. Rosenstein
    Breast Cancer Research and Treatment, 2000, 61 : 79 - 85
  • [8] Clinical prognosis of breast cancer patients with ATM missense mutations
    Singh, AM
    Dritschilo, A
    Jung, M
    Sommer, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S210 - S210
  • [9] FREQUENCY AND SPECTRUM OF ATM MUTATIONS IN BULGARIAN BREAST CANCER PATIENTS
    Angelova, Svetla G.
    Markov, Tsanko L.
    Georgieva, Elena L.
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2008, 61 (12): : 1583 - 1592
  • [10] ATM mutations associated with breast cancer
    RA Gatti
    P Concannon
    Breast Cancer Research, 7